[Resistance to antiretroviral agents: mechanism and study methods]

Area of Science:

• Virology
• Molecular Biology
• Immunology

Context:

• Human immunodeficiency virus (HIV) exhibits a high replication rate, leading to frequent errors by its reverse transcriptase enzyme.
• These errors result in a diverse spectrum of viral mutations, some of which can impact treatment efficacy.
• The emergence of antiretroviral drug resistance is a significant clinical challenge, influenced by selection pressures from medications.

Purpose:

• To explore the mechanisms of HIV mutation and the development of antiretroviral resistance.
• To discuss strategies for mitigating the risk of resistance, emphasizing early and potent treatment initiation.
• To evaluate the current role and limitations of virology tests in predicting treatment response.

Summary:

• High HIV turnover and reverse transcriptase errors generate mutations, potentially altering responses to antiretroviral agents.
• Antiretroviral drug resistance develops through selection pressure, with variable rates depending on the specific drug.
• Persistent viral replication fuels the emergence of resistant mutants; thus, early, aggressive antiretroviral therapy is recommended to suppress viral load rapidly.

Impact:

• Understanding HIV mutation dynamics is key to combating drug resistance.
• Early and effective antiretroviral treatment is essential for successful HIV management and preventing resistance.
• The clinical utility of virology tests like phenotyping and genotyping is currently limited, primarily to salvage therapy situations, with their broader application still under investigation.